| Code | Description | Claims | Bene. Records | Total Paid |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
1,005 |
937 |
$30K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
233 |
229 |
$20K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
142 |
139 |
$13K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
194 |
190 |
$9K |
| 99152 |
|
165 |
162 |
$8K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
116 |
114 |
$7K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
25 |
25 |
$5K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
57 |
56 |
$5K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
18 |
14 |
$2K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
36 |
36 |
$2K |
| 1036F |
|
178 |
168 |
$0.42 |
| 3078F |
|
124 |
119 |
$0.33 |
| 3074F |
|
81 |
76 |
$0.02 |